SECsense Logo

Inmed Pharmaceuticals Inc. 8-K Report: Key Updates as of December 13, 2024

$INM
Form 8-K
Filed on: 2024-12-18
Source
Inmed Pharmaceuticals Inc. 8-K Report: Key Updates as of December 13, 2024

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Name: Inmed Pharmaceuticals Inc.
  • CIK: 0001728328
  • SEC File Number: 001-39685
  • EIN: 98-1428279
  • Address: Suite 1445 - 885 W. Georgia Street, Vancouver, V6C 3E8
  • Phone: 604 669-7207
  1. Filing Type:
  • Form Type: 8-K
  • Filing Date: December 13, 2024
  1. Stock Information:
  • Common Shares: The company has common shares with no par value.
  • Ticker Symbol: INM
  • Exchange: NASDAQ
  1. Reporting Period:
  • As Of Date: December 13, 2024 (indicating this is a current report).
  • The report is focused on a specific day rather than a traditional quarterly or annual period.
  1. Units of Measure:
  • Financial amounts are reported in USD (U.S. Dollars).
  • Share counts are reported in shares.
  1. Context and Schema:
  • The report conforms to the XBRL (eXtensible Business Reporting Language) format, indicating it is structured for digital reporting and analysis.

Summary:

Inmed Pharmaceuticals Inc. filed an 8-K report on December 13, 2024, which provides current information about the company, including its address, stock symbol (INM), and the fact that it reports common shares without par value. The filing is structured in an XBRL format and focuses on the specified date, suggesting it may contain important updates or events that occurred on that day.